PlushCare Weight Loss review: is it worth it?
PlushCare's weight loss program offers GLP-1 prescriptions through its primary care telehealth platform.
A legitimate doctor-led GLP-1 gateway, not a discount pharmacy
PlushCare Weight Loss is worth it if you want a board-certified physician (rather than a nurse practitioner) to evaluate you, order proper labs, and prescribe a GLP-1 medication such as brand-name Wegovy or Zepbound. PlushCare leads with FDA-approved brand drugs and offers more of them than most competitors. It can also prescribe compounded semaglutide or tirzepatide in eligible states, typically as a cheaper cash-pay route when insurance denies a brand drug, so it is not a brand-only clinic. Either way, PlushCare mainly handles the consult and prescription: the medication itself is a separate cost that ranges from a few hundred dollars on cash-pay or compounded pricing to roughly $1,000+ per month at full retail without coverage.
Check PriceFrom $99/mo
Pros
- ✓Visits are with board-certified M.D.s rather than nurse practitioners, with same-day appointments often available within about 30 minutes and visits lasting roughly 15 minutes
- ✓Prescribes a wider range of FDA-approved GLP-1s than most telehealth providers (Wegovy and Zepbound for weight loss; Ozempic, Mounjaro, Saxenda, Victoza, Rybelsus, Trulicity for diabetes), so the prescriber can match the medication to your situation
- ✓Licensed in all 50 states and in-network with many major insurance plans for the visit, with help pursuing prior authorization for the medication
- ✓Requires a real obesity lab panel (typically CBC, a metabolic panel, lipids, A1C, TSH, and insulin) before prescribing, supporting safer, more individualized care
- ✓Offers a cheaper compounded semaglutide or tirzepatide cash-pay option in eligible states for patients who cannot get brand coverage, plus low recurring membership for ongoing messaging and follow-up
Cons
- ✕The membership and visit fees do not reduce drug cost, and brand-name GLP-1s can still run hundreds to roughly $1,000+ per month at full retail if insurance will not cover them
- ✕The per-visit fee (about $129 without insurance) is charged on top of the membership, and some patients report being surprised by it at checkout
- ✕Recurring complaints to the Better Business Bureau (a low rating and hundreds of complaints) describe difficult cancellations, unexpected $19.99 charges, and hard-to-reach customer support
- ✕Insurance coverage of GLP-1s for weight loss is not guaranteed and prior authorization can take up to about two weeks, delaying treatment
- ✕The lower-cost compounded option is not FDA-approved, is limited to certain states, and is generally tied to shortages or denied prior authorizations, so brand-name access can be expensive and is not always available
How it works
PlushCare itself is a telehealth platform, not a drug. You book a video visit with a board-certified physician who reviews your history, orders an obesity lab panel (typically CBC, a metabolic panel, lipids, A1C, TSH, and insulin, drawn through a lab such as Quest), and, if appropriate, prescribes a GLP-1 medication sent to your pharmacy. The medications work by mimicking gut hormones: semaglutide (Wegovy/Ozempic) activates GLP-1 receptors, while tirzepatide (Zepbound/Mounjaro) activates both GLP-1 and GIP receptors. They slow stomach emptying, reduce appetite, and increase fullness, so you tend to eat less and lose weight.
Active ingredient: Brand-name GLP-1
Effectiveness
PlushCare does not run its own trials; efficacy comes from the medications it prescribes. In the STEP 1 trial (NEJM 2021, 1,961 adults without diabetes), once-weekly semaglutide 2.4 mg (Wegovy) produced a mean 14.9% body-weight loss at 68 weeks versus 2.4% for placebo, with about 50.5% of users losing at least 15% of their body weight. In the SURMOUNT-1 trial (NEJM 2022, 2,539 adults), tirzepatide (Zepbound) produced mean reductions of about 16.0%, 21.4%, and 22.5% at the 5 mg, 10 mg, and 15 mg doses over 72 weeks, versus roughly 2.4% for placebo. Results depend on reaching and staying on an effective dose, and weight tends to return if the medication is stopped. Compounded versions are not FDA-approved and have not been tested for the same bioequivalence, so results with them may differ.
Side effects
The side effects are those of the GLP-1 drugs themselves, not the platform. The most common are gastrointestinal: nausea, vomiting, diarrhea, constipation, and bloating, usually worst when starting or increasing the dose and often easing over time. Less common but serious risks include pancreatitis, gallbladder problems (including gallstones), and dehydration-related kidney injury from severe vomiting. These drugs carry an FDA boxed warning about thyroid C-cell tumors seen in rodents (the relevance to humans is unconfirmed, but they are contraindicated with a history of MTC or MEN 2). Tell your PlushCare doctor about severe or persistent abdominal pain, which can signal pancreatitis, and seek urgent care if it is intense.
Cost
Starts at $99/mo from PlushCare.
As of 2026, PlushCare charges a membership of about $19.99/month (often with a free first month) or roughly $99/year, plus consultation fees: about $129 per visit without insurance, or a copay (often $30 or less) with in-network insurance. These fees cover only the platform and doctor; the medication is billed separately. Brand-name GLP-1s can reach roughly $1,000+ per month at full retail if insurance denies coverage, but PlushCare also advertises promotional cash-pay brand pricing at times (for example, Ozempic and Wegovy near $199/month for the first two months, then higher) and offers compounded semaglutide in eligible states at around $149/month for the lowest dose and about $299/month for higher doses, which is paid out of pocket and does not run through insurance. PlushCare can attempt prior authorization for brand drugs, but GLP-1 coverage is never guaranteed and the process can take up to about two weeks. Confirm current pricing at signup, since promotional rates change.
Is it worth it?
For US adults who qualify (BMI 30+, or 27+ with a weight-related condition) and want real physician oversight plus access to FDA-approved GLP-1s, PlushCare is a credible, convenient choice with same-day visits. Go in clear-eyed: the membership and visit fees only buy the doctor and the prescription, not the medication, and brand-name GLP-1s remain expensive unless insurance covers them. Watch the auto-renewing membership and per-visit fee so you are not surprised at checkout. This is general information, not medical advice.
Frequently asked questions
Is PlushCare legit for weight loss?
Yes. PlushCare is a legitimate telehealth company licensed in all 50 states, where board-certified physicians conduct video visits, order labs, and prescribe GLP-1 medications based on your eligibility. Its physicians are M.D.s rather than nurse practitioners. The main criticisms are about billing and subscription practices and the cost of the medication, not clinical quality.
How much does PlushCare weight loss cost?
As of 2026, expect about $19.99/month for membership (often a free first month, or roughly $99/year) plus about $129 per visit without insurance, or a copay with in-network insurance. The GLP-1 medication is billed separately and can range from a few hundred dollars on compounded or promotional cash-pay pricing to roughly $1,000+ per month for brand drugs at full retail without coverage.
Does PlushCare prescribe Ozempic, Wegovy, or Zepbound?
Yes. PlushCare physicians can prescribe FDA-approved GLP-1 medications including Wegovy and Zepbound (approved for weight loss) and Ozempic, Mounjaro, Rybelsus, Victoza, Trulicity and others (approved for type 2 diabetes), based on your medical eligibility and labs. In eligible states it can also prescribe compounded semaglutide or tirzepatide as a cash-pay alternative, typically when a brand drug is not covered.
Does PlushCare take insurance for weight loss?
PlushCare is in-network with many major insurance plans for the doctor visit and will attempt a prior authorization for your medication. However, insurance coverage of GLP-1 weight-loss drugs is not guaranteed, prior authorization can take up to about two weeks, and the cash-pay compounded option does not run through insurance at all.
Do I need lab work to get a GLP-1 from PlushCare?
Yes. PlushCare typically orders an obesity lab panel, often including CBC, a metabolic panel, lipids, A1C, TSH, and insulin, before prescribing a GLP-1, to screen for conditions that affect safety. Your doctor reviews the results with you before starting treatment.
Who qualifies for PlushCare's GLP-1 weight loss program?
Generally, US adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure or type 2 diabetes. People with a personal or family history of medullary thyroid cancer or MEN 2, active pancreatitis, or who are pregnant or breastfeeding should not use these medications. The prescribing doctor makes the final call.
How fast can I see a doctor on PlushCare?
Often the same day, frequently within about 30 minutes of booking. Video visits typically last around 15 minutes, and PlushCare offers appointments in all 50 states.
Is PlushCare hard to cancel?
Some users report difficulty. The membership auto-renews at about $19.99/month, and Better Business Bureau complaints describe surprise charges and trouble canceling or reaching customer support. Cancel through your account before any free trial ends and keep written records to avoid unexpected billing.
Does PlushCare use compounded semaglutide?
It can. PlushCare leads with FDA-approved brand-name GLP-1s, but in eligible states it also offers compounded semaglutide or tirzepatide as a lower-cost cash-pay alternative, usually when a brand drug is unavailable or not covered by insurance. Compounded versions are not FDA-approved, so discuss the trade-offs with your prescriber before choosing one.
Sources
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) — New England Journal of Medicine / PubMed (2021)
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — New England Journal of Medicine (2022)
- GLP-1 Agonists: What They Are, How They Work & Side Effects — Cleveland Clinic (2024)
- GLP-1 Medications Available Online for Weight Loss — PlushCare (2026)
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration (2025)
- PlushCare Review: Services Offered, Cost, Insurance, and More — Healthline (2025)